August 2025 credit and security agreement loan of $15.0 million at 14.0% annual interest, maturing January 11, 2029, secured by substantially all assets.
| Officer | Age | In this role | 2025 pay | Source |
|---|---|---|---|---|
|
Deborah L. Birx
Also a director
Chief Executive Officer and Director
|
70 | Not stated | $1,249,889 | |
|
David D. House
Chief Financial Officer
|
42 | Not stated | $554,770 | |
|
Pierre Kyme
Chief Business Officer
|
48 |
Since 2024
2 years
|
$791,575 |
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.
August 2025 credit and security agreement loan of $15.0 million at 14.0% annual interest, maturing January 11, 2029, secured by substantially all assets.
March 2025 credit and security agreement loan of $10.0 million at 14.0% annual interest, maturing June 1, 2027, secured by substantially all assets.
2024 secured term loan facility of $35.0 million at 14.0% annual interest, scheduled to mature June 1, 2027.
2023 secured term loan facility of $25.0 million at 14.0% annual interest, scheduled to mature June 1, 2027.
Convertible loan of $30.0 million at 8.0% annual interest, scheduled to mature June 1, 2027, convertible into common stock under stated terms.
January 2026 amendments extending the maturity dates of the credit agreements to June 1, 2027 and extending expiration dates of warrants held by Innoviva Sub to January 26, 2031.
Loading...